|
|
Article: PITILESS TUMOR MEETS OWN DEATH SENTENCE JOINT EXPRESSION OF OPPOSING GENES BESTS PANCREATIC CANCER IN VIVO; CLINICAL TRIALS IN VIEW.(Statistical Data Included)
- Article from:
- BIOWORLD Today
- Article date:
- August 28, 2001
- Author:
CopyrightCOPYRIGHT 2001 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The only good thing you can say about pancreatic cancer is that once it's diagnosed, the patient doesn't live very long - and so doesn't suffer very much.
Some 29,200 men and women in the U.S. will be diagnosed with pancreatic cancer this year, and about 28,900 of them will die in short order. Two percent will succumb within a year, and very few survive five years. Surgery, radiation and chemotherapy scarcely affect these mortality statistics. By the time of diagnosis, the disease in almost all cases will have metastasized to liver and lungs - a swift death sentence.
Pancreatic cancer sets in around 55 years of age. Its warning sign is abrupt ...